AIMS: To evaluate the expression of transforming growth factor beta1 (TGF-beta1) and fibroblast growth factor 2 (FGF-2) mRNA in stromal cells in response to injury in the presence of either TGF-beta1 or FGF-2. It has been shown previously that heparan sulfate proteoglycans and FGF-2 are present transiently during wound repair in vivo and that an increase in TGF-beta1 mRNA is detected rapidly after injury. METHODS: Primary corneal fibroblasts were cultured to confluency, serum starved, and linear wound(s) were made in medium containing TGF-beta1 or FGF-2. TGF-beta1 and FGF-2 mRNA expression were evaluated using both northern blot analysis and in situ hybridisation. Both dose dependent and time course experiments were performed. Whole eye organ culture experiments were also carried out and growth factor expression was assessed. RESULTS: Injury and exogenous TGF-beta1 increased TGF-beta1 mRNA values. The increase in expression of FGF-2 mRNA was not detected until wound closure. In contrast, FGF-2 inhibited the expression of TGF-beta1. TGF-beta1 increased TGF-beta1 mRNA stability but did not alter that of FGF-2. Migration assay data demonstrated that unstimulated stromal cells could be activated to migrate to specific growth factors. CONCLUSIONS: TGF-beta1 specifically enhances cellular responsiveness, as shown by increased stability after injury and the acquisition of a migratory phenotype. These data suggest that there is an integral relation during wound repair between TGF-beta1 and FGF-2.
AIMS: To evaluate the expression of transforming growth factor beta1 (TGF-beta1) and fibroblast growth factor 2 (FGF-2) mRNA in stromal cells in response to injury in the presence of either TGF-beta1 or FGF-2. It has been shown previously that heparan sulfate proteoglycans and FGF-2 are present transiently during wound repair in vivo and that an increase in TGF-beta1 mRNA is detected rapidly after injury. METHODS: Primary corneal fibroblasts were cultured to confluency, serum starved, and linear wound(s) were made in medium containing TGF-beta1 or FGF-2. TGF-beta1 and FGF-2 mRNA expression were evaluated using both northern blot analysis and in situ hybridisation. Both dose dependent and time course experiments were performed. Whole eye organ culture experiments were also carried out and growth factor expression was assessed. RESULTS: Injury and exogenous TGF-beta1 increased TGF-beta1 mRNA values. The increase in expression of FGF-2 mRNA was not detected until wound closure. In contrast, FGF-2 inhibited the expression of TGF-beta1. TGF-beta1 increased TGF-beta1 mRNA stability but did not alter that of FGF-2. Migration assay data demonstrated that unstimulated stromal cells could be activated to migrate to specific growth factors. CONCLUSIONS:TGF-beta1 specifically enhances cellular responsiveness, as shown by increased stability after injury and the acquisition of a migratory phenotype. These data suggest that there is an integral relation during wound repair between TGF-beta1 and FGF-2.
Authors: L Sobrin; Z Liu; D C Monroy; A Solomon; M G Selzer; B L Lokeshwar; S C Pflugfelder Journal: Invest Ophthalmol Vis Sci Date: 2000-06 Impact factor: 4.799
Authors: Elena Tassi; Kevin McDonnell; Krissa A Gibby; Jason U Tilan; Sung E Kim; David P Kodack; Marcel O Schmidt; Ghada M Sharif; Christopher S Wilcox; William J Welch; G Ian Gallicano; Michael D Johnson; Anna T Riegel; Anton Wellstein Journal: Am J Pathol Date: 2011-09-21 Impact factor: 4.307
Authors: M Korenkov; N Yuecel; J Koebke; J Schierholz; Ch Morsczeck; I Tasci; E A M Neugebauer; M Nagelschmidt Journal: Hernia Date: 2005-05-24 Impact factor: 4.739
Authors: Stephen A K Harvey; Emily Guerriero; Nahthai Charukamnoetkanok; Jordan Piluek; Joel S Schuman; Nirmala Sundarraj Journal: Invest Ophthalmol Vis Sci Date: 2010-01-06 Impact factor: 4.799
Authors: T C Thompson; S A Tahir; L Li; M Watanabe; K Naruishi; G Yang; D Kadmon; C J Logothetis; P Troncoso; C Ren; A Goltsov; S Park Journal: Prostate Cancer Prostatic Dis Date: 2009-07-07 Impact factor: 5.554